Japan vs Malaysia: Number of isolates tested for ceftriaxone
Japan
134
in 2020
Malaysia
132
in 2020
Japan rank
22nd
Malaysia rank
23rd
Number of isolates tested for ceftriaxone over time
- Japan
- Malaysia
How they compare
Japan currently reports 134 against 132 in Malaysia, a difference of 2.
Across all 5 years both countries report, Japan has been ahead every year.
Japan ranks 22nd and Malaysia ranks 23rd of 52 countries.
Japan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Japan | Malaysia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 403 | 17 | 386 | Japan |
| 2010s | 492.67 | 129 | 363.67 | Japan |
| 2020s | 134 | 132 | 2 | Japan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of isolates tested for ceftriaxone, Japan or Malaysia?
- Japan, at 134 against 132 in Malaysia as of 2020.
- What is the difference in number of isolates tested for ceftriaxone between Japan and Malaysia?
- 2, with Japan ahead.
- How many years of comparable data are there for Japan and Malaysia?
- 5 years are reported by both, from 2009 to 2020.
- How do Japan and Malaysia rank globally for number of isolates tested for ceftriaxone?
- Japan ranks 22nd and Malaysia ranks 23rd of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of isolates tested for ceftriaxone. Statizoid refreshes it automatically from the source and publishes the full history for both places.